Golden Seeds Closes Second Fund with $26.5M

Golden Seeds, an investment firm focused on women entrepreneurs, has closed its second fund with $26.5 million in committed capital. Golden Seeds Fund 2 LP will invest across technology, life sciences and consumer goods. The fund already has eight portfolio companies, including AboutOne, maker of an online household management system; and Cognition Therapeutics, which is developing drugs for Alzheimer’s disease. Golden Seeds is based in New York.

ManagersPeopleNorth AmericaUSBriefs